Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW21052 vs Lyrica in Diabetic Neuropathic Pain
NCT01863810Phase 3Unknown
- Sponsor
- Alvogen Korea Co., Ltd.
- Start
- Aug 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pregabalin in diabetic neuropathy (2 arms), sponsored by Alvogen Korea Co., Ltd. Primary endpoint: Numerical Pain Rating Scale at 8 weeks. Status: unknown.
02
Drugs
pregabalin
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on NCT01863810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863810.